Evidence map›Paper›PMID 16402195›Full record

ArticlePsychopharmacology2006

Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers.

Christine E Marx, William T Trost, Lawrence Shampine, Frederique M Behm, Louis A Giordano, Mark W Massing, Jed E Rose

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00538070 (The Effects of Glycine Transport Inhibition on Brain Glycine Concentration), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00538070 nacompletednot on this mapstarted 2007, after this paper: background citation

The Effects of Glycine Transport Inhibition on Brain Glycine Concentration

TypeinterventionalSponsorMassachusetts General HospitalRan2007 to 2012Enrolled68ConditionsSchizophreniaArmsSarcosine
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Trial
  3. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Trial
  4. Trial
  5. Trial
  6. DHEA enhances emotion regulation neurocircuits and modulates memory for emotional stimuli.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2013
    Trial
  7. Trial
  8. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2009
    Trial
  9. Salivary stress biomarkers of recent nicotine use and dependence.The American journal of drug and alcohol abuse · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Smoking behaviour and mental health disorders--mutual influences and implications for therapy.International journal of environmental research and public health · 2013
    Review
  17. Article
  18. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Christine E MarxDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, and Durham Veterans Affairs Medical Center, Durham, NC 27710, USA. marx0001@mc.duke.edu
William T Trost
Lawrence Shampine
Frederique M Behm
Louis A Giordano
Mark W Massing
Jed E Rose
Duke Medical Center · USDuke University · USDuke University Hospital · USDurham VA Medical Center · US

Funding

Neurosteroids and SchizophreniaK23MH065080 · NIMH · DUKE UNIVERSITY · PI MARX, CHRISTINE E · 2001 to 2005
$856k
Clinical Research Training in Geriatric Mood DisordersT32MH070448 · NIMH · DUKE UNIVERSITY · PI BLAZER, DAN GERMAN · 2004 to 2008
$420k
NIMH NIH HHS K23 MH 65080NIMH NIH HHS T32 MH70448
6 · The paper itself

Abstract

rationaleNicotine administration alters neuroactive steroids in rodent models, and serum levels of the neuroactive steroid DHEAS (dehydroepiandrosterone sulfate) appear to be higher in smokers. These molecules may be relevant to tobacco addiction and affective symptoms.

objectivesThis study aims to investigate DHEAS, allopregnanolone, pregnenolone, and other steroids in male smokers to determine potential associations with nicotine dependence severity and negative affect. MATERIALS AND

methodsAllopregnanolone and pregnenolone serum levels were determined by gas chromatography/mass spectrometry, while DHEAS and other steroid levels were determined by radioimmunoassay in 28 male smokers. Correlational analyses were performed to determine potential associations with rating measures, including the Fagerstrom Test for Nicotine Dependence (FTND), the addiction subscale of the Ikard Smoking Motivation Questionnaire (ISMQ), the craving item on the Reasons to Smoke (RTS) Questionnaire, and the negative affect and craving subscales of the Shiffman-Jarvik Withdrawal Questionnaire.

resultsDHEAS levels were inversely correlated with the negative affect subscale of the Shiffman-Jarvik Withdrawal Questionnaire (r=-0.60, p=0.002) and the RTS craving item (r=-0.43, p=0.03), and tended to be inversely correlated with the FTND scores (r=-0.38, p=0.067) and the ISMQ addiction subscale (r=-0.38, p=0.059), adjusting for age. Allopregnanolone levels were positively correlated with cotinine levels (r=0.57, p=0.006); pregnenolone levels tended to be positively correlated with cotinine levels (r=0.40, p=0.066).

conclusionsDHEAS levels were inversely correlated with negative affect and craving measures, and may predict nicotine dependence severity. Allopregnanolone levels were positively correlated with cotinine levels, suggesting that this neuroactive steroid may be upregulated in smokers. Neuroactive steroids may represent novel smoking cessation agents.

Indexed as

AdultAffectAndrostenesCotinineEstradiolHumansMalePregnanesSalivaSmokingTobacco Use DisorderAndrostenesCotinineEstradiolPregnanes

Identifiers

PMID16402195
OpenAlexW2053374937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.